News|Articles|July 29, 2022

COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of July 29, 2022

Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

US COVID-19 vaccination & booster dose status

US COVID-19 vaccination status according to the Centers for Disease Control and Prevention (CDC) as of July 27, 2022, at 6:00 AM, EDT:

Fully vaccinated plus 2 booster doses:

• Aged ≥50 years 30.9%

• Aged ≥65 years 37.8%

Fully vaccinated plus 1 booster dose:

• Total US population 48.3%

Fully vaccinated in key age groups:

• Total US population 67.2%

• Aged ≥5 years 71.5%

• Aged ≥65 years 91.9%

US confirmed cases of COVID-19 and deaths

Confirmed US cases of COVID-19 and related deaths according to the Johns Hopkins COVID-19 interactive map, as of July 29, 2022 at 3:46 PM, EDT.

3 states with highest number of new cases in past 28 days

• California 514 093

• Texas 331 053

• Florida 296 228

• Total US confirmed cases 91 201 657

• Total US confirmed deaths 1 029 502

Global total COVID-19 confirmed cases, deaths, vaccine doses administered:

• Cases 575 483 721

• Deaths 6 397 196 • Vaccine doses administered 11 959 376 049

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!

COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of July 29, 2022

US COVID-19 vaccination & booster dose status

Fully vaccinated plus 2 booster doses:

• Aged ≥50 years 30.9%

• Aged ≥65 years 37.8%

Fully vaccinated plus 1 booster dose:

• Total US population 48.3%

Fully vaccinated in key age groups:

• Total US population 67.2%

• Aged ≥5 years 71.5%

• Aged ≥65 years 91.9%

US confirmed cases of COVID-19 and deaths

3 states with highest number of new cases in past 28 days

• California 514 093

• Texas 331 053

• Florida 296 228

• Total US confirmed cases 91 201 657

• Total US confirmed deaths 1 029 502

Global total COVID-19 confirmed cases, deaths, vaccine doses administered:

• Cases 575 483 721

• Deaths 6 397 196 • Vaccine doses administered 11 959 376 049

Newsletter

Related Content

The Adult Immunization Catch-Up Schedule: A Practical Guide for Primary Care

Undertreated Acute Pain Poses Long-Term Risks, But Prescription Opioids Still Do, Too ...

Diagnosing DVT: Clinical Pearls for Challenging Presentations

Identifying and Managing Vascular Disease in Primary Care: A Q&A With Family Physician Kabiul Haque, MD

New Menopause Survey Finds Energy Loss, Poor Sleep, and Seasonal Symptoms Most Disruptive

Latest CME

Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (Cope Credit)

Interventional Glaucoma: The Convergence of Surgical Innovation and Therapeutic Hope

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Southern Florida Psychiatry Conference

Expert Illustrations and Commentaries™: The Role of the Paracellular Pathway in the Management of Hyperphosphatemia in CKD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Addressing Pivotal Updates in AML – Expert Perspectives on Individualizing Management for Special Populations

Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy

Advances In™: Taking R/R B-Cell ALL Management to the Next Level With New CAR T Approval

Innovations in MDS Care: Navigating New Treatment Paradigms, Breakthrough Therapies, and Emerging Clinical Evidence

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

Transforming Treatment in Small Cell Lung Cancer: How Recent Trials Are Shaping Treatment Decision-Making and Future Therapies

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Identifying and Treating CIDP in the Modern Era

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

Breast Cancer Symposia in San Antonio

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

(COPE Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care

(CME Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

(COPE Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

Addressing Racial Disparities in Multiple Myeloma: Forging a Path Towards Health Equity in Clinical Trials and Everyday Practice

(CME Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Evolving Strategies and Emerging Agents in PTCL: Subtypes, Mutations, and Modern Therapies

Community Practice Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2- Breast Cancer

Burst CME™: Addressing Diagnostic Challenges and Identifying Targets for Treatment in LCNEC-L

Burst CME™: Exploring Diagnosis and Testing Innovations for Targetable Mutations in SCLC

Community Practice Connections™: 21st Annual Meeting of the International Society of Gastrointestinal Oncology

Medical Crossfire®: Optimal Approaches to Evaluating and Addressing Pain in the Patient With Sickle Cell Disease

Burst CME™: Advanced Diagnostic and Testing Approaches for Mutation-Targetable Management of NSCLC

Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

Addressing Health Care Inequities™: Taking a More Mindful Approach to the Care of Every Patient Presenting With ATTR-CM

Clinical Case Vignette Series™: 3rd Annual International Congress on Pediatric Oncology

Epithelioid Sarcoma: Applying Clinical Updates to Real Patient Cases

Collaborating Across the Continuum®: Identifying and Treating Epithelioid Sarcoma

Real Psychiatry 2026

23rd Annual Winter Lung Cancer Conference®

EnVision Summit

22nd Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

43rd Annual Miami Breast Cancer Conference®

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 67th ASH Annual Meeting